Shamez Ladhani to Meningococcal Vaccines
This is a "connection" page, showing publications Shamez Ladhani has written about Meningococcal Vaccines.
Connection Strength
5.115
-
Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England. Emerg Infect Dis. 2021 Sep; 27(9):2495-2497.
Score: 0.724
-
Aseptic meningitis associated with routine infant immunisation visits that include the group B meningococcal vaccine, 4CMenB. Arch Dis Child. 2019 12; 104(12):1237-1238.
Score: 0.636
-
Growing evidence supports 4CMenB effectiveness. Lancet Infect Dis. 2018 04; 18(4):370-371.
Score: 0.571
-
The yin and yang of fever after meningococcal B vaccination. Arch Dis Child. 2017 10; 102(10):881-882.
Score: 0.559
-
Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term Eculizumab. Pediatrics. 2017 Sep; 140(3).
Score: 0.553
-
Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015-2016. Emerg Infect Dis. 2017 07; 23(7):1184-1187.
Score: 0.551
-
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet. 2016 12 03; 388(10061):2775-2782.
Score: 0.524
-
Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16. Euro Surveill. 2019 Jan; 24(1).
Score: 0.152
-
B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents. BMJ Open. 2018 07 10; 8(7):e020988.
Score: 0.147
-
Safety of meningococcal group B vaccination in hospitalised premature infants. Arch Dis Child Fetal Neonatal Ed. 2019 Mar; 104(2):F171-F175.
Score: 0.145
-
Estimating primary care attendance rates for fever in infants after meningococcal B vaccination in England using national syndromic surveillance data. Vaccine. 2018 01 25; 36(4):565-571.
Score: 0.142
-
Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine. Vaccine. 2017 10 13; 35(43):5814-5818.
Score: 0.139
-
Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak? J Infect. 2017 08; 75(2):95-103.
Score: 0.137
-
Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment. Lancet Infect Dis. 2017 07; 17(7):754-762.
Score: 0.135